StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3030% above fair value
$698.34+15.69 (+2.30%)

Close on Nov 3, 2026Market cap $258.21BP/E 36.9Yield 0.25%

Thermo Fisher Scientific Segment Income Margin — Life Sciences Solutions by Quarter

Segment Income Margin — Life Sciences Solutions (%)

QuarterlyAnnual

Thermo Fisher Scientific Segment Income Margin — Life Sciences Solutions: 37.6% in Q3 2026, up 0.2 pts from a year earlier.

Latest, Q3 2026
37.6%
Period ended Sep 30, 2026
Change on a year earlier
+0.2 pts
37.4% in Q3 2025
History
20 quarters
Since Q3 2021
Sources
8
Documents cited below

Where the Q3 2026 figure comes from

“LSS: Segment income margin 35.6% 36.8% 37.4% 35.5% 36.3% 36.2% 37.0% 37.6%”

Source: Q3 2026 Reconciliation of Financial Information ↗

Reported in IR Financial Reconciliation Package & SEC MD&A.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSegment Income Margin — Life Sciences Solutions (%)Year on yearSource
Q3 2026Sep 30, 202637.6%+0.2 ptsQ3 2026 Reconciliation of Financial Information ↗
Q2 2026Jun 30, 202637.0%+0.2 ptsQ3 2026 Reconciliation of Financial Information ↗
Q1 2026Mar 31, 202636.2%+0.6 ptsQ3 2026 Reconciliation of Financial Information ↗
Q4 2025Dec 31, 202535.5%-1.1 ptsQ3 2026 Reconciliation of Financial Information ↗
Q3 2025Sep 30, 202537.4%+2.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q2 2025Jun 30, 202536.8%+0.1 ptsQ3 2026 Reconciliation of Financial Information ↗
Q1 2025Mar 31, 202535.6%-1.2 ptsQ3 2026 Reconciliation of Financial Information ↗
Q4 2024Dec 31, 202436.6%+0.4 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q3 2024Sep 30, 202435.4%-0.5 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q2 2024Jun 30, 202436.7%+3.5 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q1 2024Mar 31, 202436.8%+4.8 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q4 2023Dec 31, 202336.2%+2.1 ptsQ4 & FY2024 Reconciliation of Financial Information ↗
Q3 2023Sep 30, 202335.9%+0.8 ptsQ4 & FY2024 Reconciliation of Financial Information ↗
Q2 2023Jun 30, 202333.2%-7.1 ptsQ4 & FY2024 Reconciliation of Financial Information ↗
Q1 2023Mar 31, 202332.0%-19.4 ptsQ4 & FY2024 Reconciliation of Financial Information ↗
Q4 2022Dec 31, 202234.1%–SEC Form 8-K (8k_2023Q4, filed 2024-01-31) ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Segment Income Margin — Life Sciences Solutions (%), quarterly Q3 2021–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/seg-margin-lss

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.

See a number that looks wrong?